• Manufacturing

WHP completes new cleanroom and production facilities for a leading UK MHRA approved and NHS Accredited Specials Manufacturing Company

New state of the art cleanroom and production facilities for a leading UK MHRA approved and NHS Accredited Specials Manufacturing Company will assist them in their goal of becoming a centre of medical cannabis excellence for the UK. Multi-disciplinary engineering company WHP were awarded the contract to design, build and validate a state-of-the-art manufacturing pharmaceutical cleanroom and food production facility.

WHP completes the manufacture of their largest modular build project

Multi-disciplinary engineering company WHP were awarded the contract to design and build a fully modularised containment facility. The project comprised the design and manufacture of 122 cGMP modules, making it one of the largest modular cGMP facilities in Europe.

Discovery Park & National Horizons Centre agree partnership

A partnership between the National Horizons Centre and Discovery Park, the Life Sciences Opportunity Zone for ambitious companies, is promising to bring opportunities to both organisations.

Charles River Laboratories Completes the Acquisition of Cognate BioServices

Cognate BioServices and its subsidiary Cobra Biologics have been acquired by Charles River

Altasciences Doubles Square Footage of Their CDMO Facility

Altasciences Doubles Square Footage of Their CDMO Facility

BioPharma Dynamics present their comprehensive process solutions for the Cell and Gene Therapy industry

Curating their extensive portfolio of process solutions to serve a multitude of cell therapy applications, BioPharma Dynamics are utilising their infrastructure and industry experience, to support the UK’s ever-growing cell and gene therapy sector.

Cytiva and Longitude - a Financial Times company - reveal five major challenges for the industry in new Global Biopharma Resilience Index

A new survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation.

Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie

Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited (“The ABL site”) in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions.

Cognate BioServices, and its gene therapy division Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe

Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project

Late Model Lab and Solid Dose Equipment Available in Massachusetts, USA

Leading asset management company, EquipNet, is working with a leading clinical-stage biopharmaceutical company to sell through surplus laboratory/analytical and solid dose equipment.